Machine-Learning Vaccine Design Using Temporal Pathogen Sequences
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for selecting candidate vaccine antigens are inadequate in addressing the complexity of modern pathogenic strains, leading to suboptimal vaccine effectiveness, particularly in seasons with thousands of isolates, achieving less than 50% vaccine effectiveness.
Innovation Solution
A system utilizing machine learning models, including recurrent neural networks, to predict molecular sequences that will generate a maximized aggregate biological response or effective coverage against multiple pathogenic strains by training driver models on temporal sequence data and selecting the most effective models based on translational responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to select candidate vaccine antigens, then the testing process is simple and straightforward, but the vaccine effectiveness is suboptimal (less than 50%) when facing complex modern pathogenic strains with thousands of isolates
Solution Approach 1:
The patent replaces traditional mechanical/experimental vaccine selection methods with an AI-based machine learning system. The system uses neural networks to process temporal sequence data of pathogenic strains and predict molecular sequences that will generate maximized aggregate biological responses, thereby selecting vaccine candidates with higher effectiveness against diverse strains.
Solution Approach 2:
The patent introduces machine learning models as intermediary components between the complex pathogenic strain data and the vaccine selection process. The neural networks act as mediators that process temporal sequence data, predict molecular sequences, and identify optimal vaccine candidates, enabling more effective selection without direct complex experimental testing of all possibilities.
2Adaptability or versatility
If machine learning models are used to predict molecular sequences, then vaccine effectiveness against multiple pathogenic strains is improved, but the system complexity and computational requirements increase
Solution Approach 1:
The patent develops a universal machine learning system that can handle multiple pathogenic strains through a single integrated framework. The neural networks are trained on temporal sequence data from various strains and can predict molecular sequences effective against multiple strains simultaneously, providing broad coverage without requiring separate specialized systems for each strain type.
Solution Approach 2:
The patent performs preliminary training of the machine learning models on historical temporal sequence data before actual vaccine selection. This pre-training phase allows the system to learn patterns from past pathogenic strain evolution and prepare predictive models that can quickly adapt to new strain combinations, reducing the need for complex real-time analysis during vaccine development.
3Reliability
If rigorous testing protocols are applied to candidate antigens, then the reliability of vaccine selection is improved, but the time required for development increases
Solution Approach 1:
The patent uses machine learning predictions to identify and prioritize the most promising vaccine candidates before they enter rigorous testing protocols. By using AI to pre-filter and rank potential antigens based on predicted effectiveness against temporal sequence data, the system can skip unnecessary testing of low-potential candidates and focus resources on the most promising options, thereby reducing overall development time while maintaining reliability.
Solution Approach 2:
The patent implements feedback mechanisms where the machine learning models continuously learn from experimental results and update their predictions. The system uses translational responses from biological assays to refine its molecular sequence predictions, creating an iterative feedback loop that improves selection accuracy over time and reduces the number of testing iterations needed to confirm viable candidates.
Data Source
AI summary
A system for designing vaccines includes one or more processors, and computer storage storing executable computer instructions in which, when executed by the one or more processers, cause the one or more processors to perform one or more operations. The one or more operations include applying, to a first temporal sequence data set, a plurality of driver models configured to generate output data representing one or more molecular sequences. The one or more operations include, for each of the plurality of driver models, training the driver model. The one or more operations include selecting, based on one or more trained translational responses, a set of trained driver models of the plurality of driver models. The one or more operations include selecting, based on second translational response data, a subset of trained driver models of the set of trained driver models.